Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization

Vascular Pharmacology

Volumn 46, Issue 2, 2007, Pages 77-84

  Jackson, Steven J T ^a   Singletary, Keith W ^b   Venema, Richard C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Angiogenesis; Microtubules; Mitotic arrest; Sulforaphane

Indexed keywords

HEMOGLOBIN; MATRIGEL; SULFORAPHANE; TUBULIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; AORTA; ARTICLE; BIOACCUMULATION; CELL CYCLE G2 PHASE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; COW; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HEMOGLOBIN DETERMINATION; IMMUNOFLUORESCENCE TEST; MICROTUBULE ASSEMBLY; MITOSIS INDEX; MITOSIS INHIBITION; MITOSIS RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICARCINOGENIC AGENTS; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOTHELIAL CELLS; FEMALE; INJECTIONS, SUBCUTANEOUS; LAMININ; MICE; MICE, INBRED BALB C; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; SUBCUTANEOUS TISSUE; THIOCYANATES; TIME FACTORS; TUBULIN MODULATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845593776     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.06.015     Document Type: Article

References (31)

1. Barcelo S., Gardiner J.M., Gescher A., and Chipman J.K. CYP2El-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17 2 (1996) 277-282
2. Besson A., and Yong V.W. Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas. J. Neurooncol. 51 (2001) 245-264
3. Ellis L.M., and Fidler I.J. Tumor Angiogenesis. In: Mendelsohn J., Howley P.M., Israel M.A., and Liotta L.A. (Eds). The Molecular Basis of Cancer. 2nd ed. (2001), W.B. Saunders Company 173-185
4. Buckley B.J., Mirza Z., and Whorton A.R. Regulation of Ca(2+)-dependent nitric oxide synthase in bovine aortic endothelial cells. Am. J. Physiol., Cell Physiol. 269 3 (1995) C757-C765
5. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6 4 (2000) 389-398
6. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 6801 (2000) 249-257
7. Castedo M., Perfettini J.-L., Roumier T., Andreau K., Medema R., and Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23 (2004) 2825-2837
8. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 56 3 (1999) 794-814
9. Fukumura D., and Jain R. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev. 17 l (1998) 77-89
10. Fukumura D., Gohongi T., Kadambi A., Izumi Y., Ang J., Yun C., Buerk D., Huang P., and Jain R. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. U. S. A. 98 5 (2001) 2604-2609
11. Gamet-Payrastre L., Lumeau S., Gasc N., Cassar G., Rollin P., and Tulliez J. Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro. Anticancer Drugs 9 (1998) 141-148
12. Gamet-Payrastre L., Li P., Lumeau S., Cassar G., Dupont M.-A., Chevolleau S., Gasc N., Tuilliez J., and Terce F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 colon cancer cells. Cancer Res. 60 (2000) 1426-1433
13. Hahn W.C. Immortalization and transformation of human cells. Mol. Cells 13 3 (2002) 351-361
14. Hood J.D., Meininger C.J., Ziche M., and Granger H.J. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am. J. Physiol, Heart Circ. Physiol. 274 3 (1998) H1054-H1058
15. Ignarro L., Cirino G., Casini A., and Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 34 6 (1999) 879-886
16. Jackson S.J.T., and Singletary K.W. Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 25 2 (2004) 219-227
17. Jackson S.J.T., and Singletary K.W. Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J. Nutr. 134 (2004) 2229-2236
18. Jackson S.J.T., and Venema R.C. Quercetin inhibits eNOS, microtubule polymerization, and mitotic progression in bovine aortic endothelial cells. J. Nutr. 136 (2006) 1178-1184
19. Kroll J., and Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem. Biophys. Res. Commun. 252 3 (1998) 743-746
20. Michel L., Benezra R., and Diaz-Rodriguez E. MAD2 dependent mitotic checkpoint defects in tumorigenesis and tumor cell death. Cell Cycle 3 8 (2004) 990-992
21. Morbidelli L., Donnini S., and Ziche M. Role of nitric oxide in the modulation of angiogenesis. Curr. Pharm. Des. 9 7 (2003) 521-530
22. Neumeister P., Albanese C., Balent B., Greally J., and Pestell R.G. Senescence and epigenetic dysregulation in cancer. Int. J. Biochem. Cell Biol. 34 (2002) 1475-1490
23. Noiri E., Peresleni T., Srivastava N., Weber P., Bahou W.F., Peunova N., and Goligorsky M.S. Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. Am. J. Physiol., Cell Physiol. 270 3 (1996) C794-C802
24. Papapetropoulos A., Garcia-Cardena G., Madri J.A., and Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100 12 (1997) 3131-3139
25. Pluda J.M. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. From the Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment, Diagnosis, and Centers (2001), National Cancer Institute, Rockville, MD. http://angioworld.com/pluda.htm Website: http://angioworld.com/pluda.htm [last accessed February 21,2006].
26. Sheweita S.A., and Tilmisany A.K. Cancer and phase II drug-metabolizing enzymes. Curr. Drug Metab. 4 1 (2003) 45-58
27. Steele V.E. Current mechanistic approaches to the chemoprevention of cancer. J. Biochem. Mol. Biol. 36 l (2003) 78-81
28. Zhang Y., Talalay P., Cho C.-G., and Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 2399-2403
29. Zhang Y., Kensler T.W., Cho C.-G., Posner G.H., and Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3147-3150
30. Ziche M., and Morbidelli L. Nitric oxide and angiogenesis. J. Neurooncol. 50 1-2 (2000) 139-148
31. Zollner S., Aberle S., Harvey S.E., Polokoff M.A., and Rubanyi G.M. Changes of endothelial nitric oxide synthase level and activity during endothelial cell proliferation. Endothelium 7 3 (2000) 169-184